Physician profile
Cameron Williams
NPI 1902395957
$4,149.24
in general payments reported to CMS, 2019-2025
34 companies · $716 in 2025
The $716 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2021: $674 · 2022: $685 · 2023: $1,148 · 2024: $677 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,291 · Education: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,291.25 |
| Education | $248.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,034.22 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Astrazeneca Pharmaceuticals LP | $584.22 | 2019-2025 | Wainua, Lokelma, Airsupra |
| Acadia Pharmaceuticals INC | $528.25 | 2021-2025 | Nuplazid |
| Otsuka America Pharmaceutical, INC. | $461.88 | 2022-2025 | Rexulti, Nuedexta |
| Sumitomo Pharma America, INC. | $249.89 | 2023 | Gemtesa, Aptiom |
| Neurocrine Biosciences, INC. | $138.67 | 2022-2025 | Ingrezza |
| Sunovion Pharmaceuticals INC. | $121.81 | 2021-2022 | |
| Ucb, INC. | $119.98 | 2021-2024 | Briviact, Nayzilam |
| Amneal Pharmaceuticals LLC | $117.05 | 2025 | Crexont |
| Pfizer INC. | $114.61 | 2021-2024 | |
| Lilly USA, LLC | $111.55 | 2022-2025 | Mounjaro, Zepbound |
| Verona Pharma, INC. | $75.07 | 2025 | Ohtuvayre |
| Bayer Healthcare Pharmaceuticals INC. | $74.57 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $52.17 | 2022 | |
| Novo Nordisk INC | $36.41 | 2024-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.03 | 2024 | |
| Scilex Pharmaceuticals INC. | $20.05 | 2022 | |
| Glaxosmithkline, LLC. | $18.99 | 2024 | Trelegy Ellipta, Arexvy |
| Janssen Pharmaceuticals, INC | $18.85 | 2025 | Invega Sustenna |
| Avanir Pharmaceuticals, INC. | $18.80 | 2022 | |
| Daiichi Sankyo INC. | $18.63 | 2025 | Injectafer |
| Corium, LLC | $18.46 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.44 | 2025 | Caplyta |
| Lundbeck LLC | $17.78 | 2024 | Rexulti |
| Biogen, INC. | $17.76 | 2021 | |
| Paratek Pharmaceuticals, INC. | $17.62 | 2021 | |
| Argenx US, INC. | $17.40 | 2025 | Vyvgart Hytrulo |
| Axsome Therapeutics, INC. | $16.61 | 2023 | Auvelity |
| Xeris Pharmaceuticals, INC. | $15.85 | 2022 | |
| Merck Sharp & Dohme LLC | $15.14 | 2022 | |
| Urovant Sciences INC | $14.50 | 2022 | |
| Sk Life Science, INC. | $14.48 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.89 | 2022 | |
| Mylan Specialty L.P. | $12.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.